Compare VFF & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VFF | PEPG |
|---|---|---|
| Founded | 1989 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.2M | 207.1M |
| IPO Year | 2013 | 2022 |
| Metric | VFF | PEPG |
|---|---|---|
| Price | $2.91 | $3.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | N/A | ★ $11.17 |
| AVG Volume (30 Days) | ★ 1.2M | 1.0M |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 184.38 | 25.61 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $215,937,000.00 | N/A |
| Revenue This Year | $12.19 | N/A |
| Revenue Next Year | $15.82 | N/A |
| P/E Ratio | $35.75 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.81 | $1.17 |
| 52 Week High | $4.99 | $7.80 |
| Indicator | VFF | PEPG |
|---|---|---|
| Relative Strength Index (RSI) | 76.55 | 59.32 |
| Support Level | $2.75 | $1.47 |
| Resistance Level | $2.94 | $3.14 |
| Average True Range (ATR) | 0.13 | 0.20 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 86.82 | 27.27 |
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.